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INTRODUCTION
Laparoscopyassisted colectomy (LAC) was
first reported in 1991１). Laparoscopic colonic re-
sections are feasible and safe, offering better
cosmetic results than open surgery in the short
term as well as better pain control, bowel func-
tion, and a shorter postoperative stay24). Re-
cently, Lacy et al.5) published the first random-
ized trial addressing this issue. These authors
reported unforeseen better longterm survival
for nodepositive patients treated by LAC. We
present the shortand midterm LAC results in
a singleinstitution.
PATIENTS AND METHODS
The indications for laparoscopic surgery
used to manage colorectal cancer have gradu-
ally expanded in our institution based on the
preoperative diagnosis of the tumor. When we
started LAC in 1998, only T1 tumors in the co-
lon were targeted. In 2001, T2 tumors, and in
2003 T3 tumors in the colon and the rectosig-
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ABSTRACT
Background: Laparoscopyassisted colec-
tomy (LAC) has gained acceptance for the treat-
ment of colon cancer. Objective: To evaluate the
use and outcomes of LAC. Patients: Patients
who underwent LAC (n = 176) for colon and
rectosigmoid cancer (20012008). Results: There
were 97 men (55.1%) and 79 women(44.9%),
whose median age was 67.5 years (range, 3399
years). The median operating time for patients
who underwent LAC was 216 minutes (range,
70440). The median blood loss was 60 ml (range
10610 ml). Intra and postoperative complica-
tions occurred in 3 (1.7%) and 16 patients (9.1%),
respectively. The morbidity rate of patients was
0%. The overall survival rates for 3 years were
100.0%, 97.5%, 95.9%, 90.1% and 77.9% for stages
0,Ⅰ,Ⅱ,Ⅲa andⅢb, respectively. The relapsefree
survival rates for 3 years were 100.0%, 100.0%,
90.1%, 65.7% and 62.3% for stages 0, Ⅰ,Ⅱ,Ⅲa and
Ⅲb, respectively. Conclusion: This study con-
firmed the favorable shortand midterm opera-
tive results in patients who underwent LAC.
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moid were included. Patients with bulky tu-
mors, those with bowel obstruction, and those
who did not consent to laparoscopic surgery
were excluded. Between April 2001 and March
2008, 176 consecutive selected patients with co-
lon and rectosimoid cancer underwent laparo-
scopic surgery in our institution. The patients
underwent examinations of blood, serum carci-
noembryonic antigen, colonoscopy, barium en-
ema or air enema, chest radiography, and com-
puted tomography of the abdomen and pelvis
for preoperative staging of tumor extent. No pa-
tients in this study received preoperative radia-
tion or chemoradiation. They received mechani-
cal bowel preparation with polyethylene glycol
electrolyte solution for two days before surgery
and prophylactic intravenous antibiotics were
administered at the induction of anesthesia. A
urinary catheter was inserted after the patient
was put under general anesthesia. A nasogastric
tube was routinely used overnight after the op-
eration.
In patients who underwent attempted la-
paroscopic resections, the peritoneal cavity was
accessed by the open method and carbon diox-
ide was insufflated to maintain intraperitoneal
pressure of 8 to 10 mm Hg. Vessels were con-
trolled with endoscopic clips intracorporeally in
most circumstances. Following bowel mobiliza-
tion and vessel division, the tumorbearing seg-
ment was retrieved through an incision at a
convenient site with adequate wound protec-
tion. In case of a rightsided to sigmoid colonic
lesion, resection and anastomosis were per-
formed extracorporeally using linear staplers.
Rectosigmoid anastomosis was performed using
a circular stapler, which was inserted tran-
sanally.
Operative mortality was defined as death
that occurred during the same hospital stay or
within 30 days following the primary operation.
Operative morbidity was defined as complica-
tions that contributed to prolonged hospital stay
or led to additional interventions or procedures.
Adjuvant chemotherapy was offered to pa-
tients with stage III disease and stage II disease
in the presence of other risk factors. The deci-
sion was made jointly by the surgeons and the
patient. The policy of adjuvant therapy did not
change during the study period, and 5
fluorouracilbased regimens were used for the
majority of patients.
POSTOPERATIVE SURVEILLANCE
Patients were followedup at intervals of 3
months during the first 3 years and at 6month
intervals from the fourth to fifth year. Thereaf-
ter, the patients were observed yearly. Follow
up surveillance was performed on symptom and
sighn, physical examination, blood tests, the
level of serum carcinoembryonic antigen, endo-
scopic examination and CT scans.
DATA COLLECTION AND STATISTICAL
ANALYSYS
Data on the patients' demographics, medical
mortality, locations of the tumors, pathological
classification (the Japanese Research Society
classification for colorectal cancer)6), operative
details, postoperative outcomes, and followup
status were studied retrospectively.
RESULTS
There were 97 men (55.1%) and 79 women
(44.9%), whose median age was 67.5 years
(range, 3399 years). Tumor locations and patho-
logical classification are shown in Table 1. Pallia-
tive resection was performed for 12 patients
(6.9%), because of the presence of unresectable
distant metastasis (n = 12) .
Between April 2001 and March 2008, 176
consecutive selected patients with colon and
rectosimoid cancer underwent laparoscopic sur-
gery in our institution. When we performed
LAC in 2001, only 11 patients who had T1 and
T2 tumors in the colon were targeted. However,
the rate of LAC for all colon cancers rose to
over 70% between April 2007 and March 2008,
as shown in Figure 1.
The operative details and complications are
shown in Table 2. The median operating time
for patients who underwent LAC was 216 min-
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utes (range, 70440 years). The median blood
loss was 60 ml (range 10610 ml). In those pa-
tients with successful laparoscopic procedures,
the permissible length of the incision was 4.06.9
cm. Eleven patients underwent initial la-
paroscopy that required conversion. The rea-
sons for conversion were advanced tumors in-
vading neighboring organs (n = 2), adhesions (n
= 4), inability to locate the tumors (n = 2), and
difficulty of the surgical technique (n =3).
Intra and postoperative complications oc-
curred in 3 (1.7%) and 16 patients (9.1%), respec-
tively, as shown in Table 2. The causes of in-
traoperative complications were hemorrhage (n
= 1) ureteric injury (n = 2), and vessel/bladder
injury (n = 1). The causes of postoperative mor-
bidity were wound infection (n = 7), intraab-
dominal abscess (n = 1), anastomotic stenosis (n
= 1), bowel obstruction (n = 2), cholelithiasis (n =
2), colitis (n = 2), and duodenal ulcer (n = 1). The
mortality rate of patients was 0% in the intra
and postoperative periods (030 days).
SURVIVAL ANALYSIS
The average followup interval of the sur-
viving patients with nondisseminated disease
(stages 0III) was 33.3month. The overall sur-
vivals and relapsefree survivals of patients
with stage 0 to stage III disease are shown in
Figures 2 and 3. The overall survival rates for 3
years were 100.0%, 97.5%, 95.9%, 90.1% and
77.9% for stages 0,Ⅰ,Ⅱ,Ⅲa andⅢb, respectively.
The relapsefree survival rates for 3 years were
100.0%, 100.0%, 90.1%, 65.7% and 62.3% for
stages 0,Ⅰ,Ⅱ,Ⅲa andⅢb, respectively.
Table １ Patient detail and Pathological classifi-
cation
number ％
Number of patients １７６
Age(mean) ６７
Sex
male ９７ ５５．１
female ７９ ４４．９
Tumor site
C ２０ １１．４
A ３６ ２０．５
T １５ ８．５
D ７ ４．０
S ６２ ３５．２
RS ３６ ２０．５
Number of patients with pathology form
Depth
M １７ ９．７
SM ２６ １４．８
MP ２３ １３．１
SS ９５ ５４．０
SE １２ ６．８
SI ３ １．７
pN stage
N０ １１８ ６７．０
N１ ４４ ２５．０
N２ １２ ６．８
N３ ２ １．１
pStage
０ １７ ９．７
Ⅰ ４１ ２３．３
Ⅱ ５９ ３３．５
Ⅲa ３３ １８．８
Ⅲb １２ ６．８
Ⅳ １４ ８．０
M stage
M (－) １６２ ９２．０
M (＋) １４ ８．０
Cur stage
CurA １６２ ９２．０
CurB ２ １．１
CurC １２ ６．８
Table ２ Operative and post operative outcome
OperativeTime (median) ２１６（７０４４０） (min)
Blood loss (median) ６０（１０６７０） (ml)
number ％
Conversion to open surgery １１ ６．３
Intraoperative complications ４ ２．３
clinicaly significant hemorrhage １ ０．６
bowel injury ０ ０．０
ureteric injury ２ １．１
vessel／bladder injury １ ０．６
others ０ ０．０
Postoperative complications １６ ９．１
wound infection ７ ４．０
abdominal abscess １ ０．６
anastomotic leakage ０ ０．０
anastomotic stenosis １ ０．６
bowel obstruction ２ １．１
others ５ ２．８
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DISCUSSION
The overall operative morbidity of all the
patients was 9.1%, which was comparable to
other highvolume centers with analysis of
large numbers of patients7, 8). Moreover, opera-
tions were performed on elderly patients with
concomitant medical diseases, and the resec-
tions were palliative for 12 patients with ad-
vanced local or distant diseases. Indeed, most
morbidities were due to medical causes.
We adopted an aggressive policy for stage
IV diseases, and resection of the primary lesion
was usually performed except in those with
very high operative risk to avoid bleeding and
obstruction due to the primary cancer. In addi-
tion, during the study period, new chemothera-
peutic agents were not widely available for pa-
tients with stage IV diseases.
The better survival of patients who had
nondisseminated disease and underwent laparo-
scopic resection was an unexpected finding. In
most reports and randomized trials, the long
term survival of patients with laparoscopic re-
section was similar to that of those who under-
went open procedures. However, better long
term survival in patients with laparoscopic re-
section has also been reported. In the study of
Lacy et al., which randomized 219 patients to
either open or laparoscopic surgery for colon
cancer, the probability of survival was better in
the laparoscopic group5). The improvement was
attributed to the better survival of patients with
stage III disease. Capussotti et al. also found
that, in lymph nodepositive patients who un-
derwent laparoscopic colonic resection, better
survival could be achieved9). The better results
might be attributable to the favorable immu-
nologic response and reduced stress responses
in patients with laparoscopy. The prospective
randomized clinical trials to address the safety
and oncologic effectiveness of LAC compared
with open colectomy (OC)10). Although one early
singleinstitution trial suggested that LAC may
result in better outcomes than OC, seven larger
subsequent multiinstitutional trials and meta
analysis have not detected considerable differ-
ences in either short or longterm outcomes
by surgical approach1117). These multicenter
Fig．１The number of operation and rate of LAC
The number of operation (OC and LAC) for colon cancer and the rate of LAC for all colon cancers rose to
over 70% between April 2007 and March 2008
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clinical trials were followed by numerous single
institution trials and cohort studies from centers
with highvolume expertise or interest in LAC,
most of which also demonstrated comparable re-
sults for LAC and OC1516,1821). Experimental and
clinical studies have shown that laparoscopy
causes a lower impairment of cellmediated im-
munitary function than open operation2224). They
have generated the hypothesis that laparoscopy
could be a more suitable technique for treating
neoplasticdiseases.
CONCLUSION
This study confirmed the favorable short
and midterm operative results in patients who
underwent laparoscopic resection of colon and
rectosigmoid cancer. The operative mortality of
LAC was 9.1%. Laparoscopicassisted colectomy
for colon and rectosigmoid cancer is feasible,
safe, and has many shortterm benefits, includ-
ing reduction of perioperative mortality. The on-
cological clearance is equivalent to the open pro-
cedure. Further work would be required also
needed to standardize the surgical expertise.
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